ENTPD1 and neoplasm: Recently, the coexpression of CD39 and CD103 on CD8+ T cells has been reported to be associated with tumor-reactive T cells in various types of solid cancers, including head and neck squamous cell carcinoma and ovarian cancer (26, 27).